|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Reported Vaccine-Preventable Diseases -- United States, 1993, and the Childhood Immunization InitiativeIn the United States, children are routinely vaccinated against nine diseases -- diphtheria, Haemophilus influenzae type b (Hib), hepatitis B, measles, mumps, pertussis, poliomyelitis (paralytic), rubella, and tetanus (1). Based on public health surveillance and epidemiologic assessment of most of these diseases, the impact of childhood vaccination on reported occurrence has been substantial (2,3): provisional surveillance data for 1993 indicate that for five of these diseases and for congenital rubella syndrome (CRS), the number of reported cases is at or near the lowest levels ever, suggesting near interruption of transmission of these diseases. This report presents provisional data for December 1993 for these 10 diseases, compares provisional data for 1993 with final data for 1992, and describes the Childhood Immunization Initiative (CII). In December 1993, state health departments reported no cases of CRS, diphtheria, or poliomyelitis, and fewer than five cases each of measles and tetanus (Table_1). In addition, no cases of indigenously acquired measles were reported that could not be linked to chains of transmission from known imported cases during September-December, the longest such period since surveillance began in 1912. Provisional data for 1993 indicate that the numbers of reported cases of CRS, diphtheria, measles, poliomyelitis, rubella, and tetanus were at or near the lowest levels ever (Table_1). Marked differences were observed in the age-specific incidence of invasive H. influenzae disease, * acute hepatitis B, mumps, and pertussis; the number of persons with reported cases for whom age was known was 1211, 11,633, 1515, and 5793, respectively. For invasive H. influenzae disease, preschool-aged (aged less than 5 years) children constituted 399 (33%) cases; for acute hepatitis B, 142 (1% **); for mumps, 275 (18%); and for pertussis, 3753 (65%). Of preschool-aged children with pertussis, 2549 (68%) were aged less than 1 year (4). Reported by: National Immunization Program, CDC. Editorial NoteEditorial Note: The findings in this report indicate that the incidences of most vaccine-preventable diseases during 1993 were at or near their lowest reported levels. However, decreases in disease burden and mortality can be sustained only by achieving and maintaining high vaccination levels among children aged 0-2 years. For example, although the incidence of measles was low during 1981- 1988, during 1989-1991, a resurgence of measles -- attributed primarily to a failure to vaccinate preschool-aged children on time (i.e., early during the second year of life) (5) -- accounted for an estimated 55,000 measles cases, 11,000 hospitalizations, and 130 deaths (CDC, unpublished data, 1993). The national response to the resurgence of measles has improved vaccination coverage among children aged 0-2 years. However, because no system has been fully established to ensure that all children complete the recommended series of 11-15 doses of vaccine by their second birthday, vaccination coverage remains unacceptably low in many areas of the United States (1,6). In 1993, the President initiated CII, a more comprehensive national response to undervaccination. The goals of CII are to 1) eliminate indigenous cases of six vaccine-preventable diseases (i.e., diphtheria, Hib disease {among children aged less than 5 years}, measles, poliomyelitis, rubella, and tetanus {among children aged less than 15 years} by 1996 ***; 2) increase vaccination coverage levels to at least 90% among 2-year-old children by 1996 for each of the vaccinations recommended routinely for children (for hepatitis B, the objective is set for 1998) (Table_2); and 3) establish a vaccination-delivery system that maintains and further improves high coverage levels. CII comprises six broad areas of activity that constitute the framework for meeting the nation's goals for 1996 and beyond:
To track progress toward achieving the goals of CII, CDC's National Immunization Program is initiating in this issue of MMWR monthly publication of a table that summarizes the number of cases of all diseases preventable by routine childhood vaccination reported during the previous month and year-to-date (provisional data) (Table_1). In addition, the table compares provisional data with final data for the previous year and highlights the number of reported cases among children aged less than 5 years -- who are the primary focus of CII. Data in the table are derived from CDC's National Notifiable Diseases Surveillance System. References
TABLE 1. Number of reported cases of diseases preventable by routine childhood vaccination -- United States, December 1993 and 1992-1993 * ==================================================================================================== No. cases among children No. cases, Total cases aged <5 years + December ---------------------- ------------------------ Disease 1993 1992 1993 1992 1993 ---------------------------------------------------------------------------------------------- Congenital rubella syndrome (CRS) 0 9 7 9 5 & Diphtheria 0 3 0 1 0 Haemophilus influenzae @ 135 1,412 1,264 592 399 Hepatitis B ** 1,330 16,126 12,396 215 142 Measles 4 2,231 281 1,116 104 Mumps 157 2,485 1,640 364 275 Pertussis 700 3,935 6,335 2,261 3,753 Poliomyelitis, paralytic ++ -- -- -- -- -- Rubella 11 157 195 24 36 Tetanus 4 44 43 0 1 ---------------------------------------------------------------------------------------------- * Data for 1992 are final and for 1993, provisional. + For 1992 and 1993, age data were available for 90% or more cases, except for 1992 age data for mumps and rubella, which were available for 84% and 64% of cases, respectively. & Age reported for five of seven persons with CRS through December 31, 1993. @ Invasive disease; H. influenzae serotype is not routinely reported to the National Notifiable Diseases Surveillance System. ** Because most hepatitis B virus infections among infants and children aged <5 years are asymptomatic (although likely to become chronic), acute disease surveillance does not reflect the incidence of this problem in this age group or the effectiveness of hepatitis B vac- cination in infants. ++ Four cases of suspected poliomyelitis were reported in 1993; four of the five suspected cases with onset in 1992 were confirmed, and the confirmed cases were vaccine-associated. ==================================================================================================== Return to top. Table_2 Note: To print large tables and graphs users may have to change their printer settings to landscape and use a small font size. TABLE 2. Vaccination coverage levels targeted by the objectives for the Childhood Immunization Initiative, by vaccine and year * -- United States =================================================================================== Vaccine 1992 Baseline + 1994 1995 1996 ------------------------------------------------------------------------------ Diphtheria and tetanus toxoids and pertussis (3-4 doses) 83% 85% 87% 90% Poliomyelitis (3 doses) 72% 75% 85% 90% Measles-mumps-rubella (1 dose) 83% 85% 90% 90% Haemophilus influenzae type b (3-4 doses) -- 75% 85% 90% Hepatitis B (3 doses) -- 30% 50% 70% & ------------------------------------------------------------------------------ * Baseline data for 1993 are not yet available. + Baseline data from 1992 National Health Interview Survey (6). & The goal is for 90% vaccination coverage by 1998. =================================================================================== Return to top. Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 09/19/98 |
|||||||||
This page last reviewed 5/2/01
|